Introduction
============

Atherosclerosis is the primary cause of cerebrovascular and cardiovascular diseases, which are the leading causes of death among adults in China ([@b1-etm-0-0-7646]). Carotid intima-media thickness (IMT) measured by ultrasound (US) as a surrogate marker for atherosclerosis is widely used in basic and clinical research ([@b2-etm-0-0-7646]--[@b4-etm-0-0-7646]). The increase in the maximum IMT (IMT~Max~) and mean IMT (IMT~Mean~) is, however, only part of the information that reflects the atherosclerotic lesions in the artery ([@b5-etm-0-0-7646],[@b6-etm-0-0-7646]). At times, they also reflect the physiological aging processes ([@b7-etm-0-0-7646]).

Atherosclerosis is an inflammatory disease with a dynamic process ([@b8-etm-0-0-7646]). Local inflammation occurs in the formation of plaque ([@b9-etm-0-0-7646],[@b10-etm-0-0-7646]), which causes roughness of the IM layer. A prospective study has revealed that the surface granulation of the carotid arterial inner wall is closely associated with cardiovascular events ([@b11-etm-0-0-7646]). Carotid intima-media roughness (IMR) refers to a variation of IMT and measures the changes as granulations of the IM layer. Due to technical limitations, few studies have quantitatively evaluated the carotid IMR by using US. The purpose of the present study was to quantitatively measure the carotid IMR and investigate its clinical value in cardiovascular risk stratification.

Materials and methods
=====================

### Study population

A total of 185 consecutive patients (mean age, 50.1±1.0 years) who underwent carotid US examination at the United Hospital of Tongji Medical College of Huazhong University of Science and Technology (Wuhan, China) between November 2013 and January 2016 were enrolled in the present study. The exclusion criteria were as follows: i) Stroke; ii) acute myocardial infarction; iii) peripheral artery disease; iv) acute inflammatory diseases; v) malignant neoplasms. All participants were screened for risk factors of cardiovascular disease and were comprehensively evaluated, including review of medical history, physical examination and laboratory tests.

Essential hypertension was diagnosed if the systolic blood pressure (BP) was ≥140 mmHg and/or the diastolic BP was ≥90 mmHg or if subjects were on BP-lowering drugs ([@b12-etm-0-0-7646]). Hyperlipidemia was diagnosed if the total cholesterol (TC) to high-density lipoprotein-cholesterol (HDL-C) ratio was \>5 or the patient was undergoing treatment with lipid-lowering drugs ([@b13-etm-0-0-7646]). Diabetes was diagnosed if the fasting plasma glucose level was ≥126 mg/dl on at least two occasions or if subjects were undergoing treatment with anti-diabetic drugs ([@b14-etm-0-0-7646]). Obesity was diagnosed if the body mass index (BMI) was ≥28 kg/m^2^ ([@b15-etm-0-0-7646]). The Framingham risk score (FRS) was used to estimate the 10-year risk of coronary heart disease (CHD) events ([@b16-etm-0-0-7646]). The smoking status included past and present smoking. The FRS was calculated by points of risk factors: Age, total cholesterol level, HDL-C level, systolic BP and smoking status.

### US examination

Carotid US was performed with a US machine (SSD-α10; Aloka) using a UST5412 probe with a transmission frequency of 5--13 MHz by a researcher, who was blinded with regard to participant history. With subjects placed in the supine position in a quiet air-conditioned room (22--24°C), the extracranial carotid arteries were visualized in the longitudinal and transverse planes. The entire length of the common carotid arteries (CCAs) and carotid bifurcations, including the internal carotid artery as far up as was possible to observe, was examined for the presence of atherosclerotic plaques. Plaque was defined as a focal structure encroaching into the arterial lumen by at least 0.5 mm or 50% of the surrounding IMT value exhibiting a plaque thickness of \>1.5 mm ([@b17-etm-0-0-7646]). The longitudinal scan images (acquired while keeping the beam parallel to the vessel wall) were stored on CD-R disks in DICOM format for off-line analysis. The left CCA within 1.5 cm of the bifurcation was visualized in the longitudinal plane by US.

### IMT and IMR

Clear longitudinal scan images of the far wall at the T-wave end frame of the cine-loop recording were selected for analysis. Measurements were made with computer-assisted analysis software by using a previously validated snake model-based segmentation method to detect the IM boundaries automatically ([@b18-etm-0-0-7646]).

The IMT and IMR were measured at the far wall of the CCA and not at the near wall, as the measurement at the near wall has a larger angle between the US beam and the vessel wall, which affects the measurement results, and because far-wall measurements are considered to have a higher validity than near-wall measurements ([@b19-etm-0-0-7646]).

IMT was defined as the distance between the lumen-intima interface and the media-adventitia interface, as reported previously ([@b20-etm-0-0-7646]). A longitudinal region of interest was selected and the IM boundaries were demarcated. IMT measurement was performed along each vertical pixel line throughout the entire target vessel in the longitudinal section ([Fig. 1](#f1-etm-0-0-7646){ref-type="fig"}). The IMT~Mean~/IMT~Max~ was obtained by calculating the average/max value of these data. IMR was obtained by calculating the standard deviation of these data.

### Reproducibility of IMR

Intra- and interobserver variability of the measurement of IMR were evaluated through blinded repeated measurements of the same imaging data set of 30 subjects on two different occasions 2 weeks apart, with a single researcher for intraobserver variability and with two different researchers for interobserver variability.

### Statistical analysis

Values are expressed as the mean ± standard error of the mean or as percentages. Student\'s t-test and analysis of variance, with Fisher\'s least significant difference post-hoc test, were used to compare the mean values of the measured variables among the groups. The chi-square test was used for categorical data. Pearson correlation coefficients were assessed in univariate analyses comparing IMR and various parameters. Multivariate linear regression analysis was performed using standard least squares to assess the independent predictive value of the IMR; odds ratios (ORs) were calculated to determine the independent contribution of IMR to carotid atherosclerosis (absence=0, presence=1). The Bland-Altman test was used to assess variability in the method. The coefficient of variation was calculated as SD(x-y)/mean(x, y) ×100%. SPSS statistical software version 13.0 for Windows (SPSS, Inc.) was used for analysis. P\<0.05 was considered to indicate statistical significance.

Results
=======

### Population characteristics

[Table I](#tI-etm-0-0-7646){ref-type="table"} presents the clinical and biochemical characteristics of the patients. Of the 185 subjects, 56 (30.3%) had hypertension, 77 (41.6%) had diabetes, 53 (28.6%) had hyperlipidemia and 52 (28.1%) were smokers. The prevalence of smokers was significantly higher in males than in females (chi-square P\<0.01), as was the BMI (t-test P\<0.01).

### Correlation between IMR, IMT and cardiovascular risk factors

A significant positive correlation was determined between IMR and FRS (r=0.438; P\<0.001; [Fig. 2A](#f2-etm-0-0-7646){ref-type="fig"}). Patients were then categorized into three groups according to FRS tertiles (ranges of score: −7-5; 5--11; 11--20); the IMR and IMT~Mean~ increased progressively and significantly with increasing tertiles of CHD risk factor score ([Fig. 2B](#f2-etm-0-0-7646){ref-type="fig"}).

A total of 40 subjects had no major CHD risk factors, 43 subjects had only one CHD risk factor, 53 subjects had two CHD risk factors and 49 subjects had three risk factors or more. Subjects with risk factors had significantly higher values of IMR and IMT~Mean~ than those without risk factors ([Fig. 2C](#f2-etm-0-0-7646){ref-type="fig"}, [Table II](#tII-etm-0-0-7646){ref-type="table"}).

Pearson correlation analysis results are demonstrated in [Table III](#tIII-etm-0-0-7646){ref-type="table"}. The IMR, similar to the IMT~Mean~, was significantly correlated with several risk factors for CHD. Multiple regression analysis was performed with IMR and IMT~Mean~ as the dependent variables and with variables that met statistical significance in the univariate analysis of IMR and IMT~Mean~. The analysis indicated that Age, SBP, smoking status and TC/HDL-C ratio were independently associated with IMR and IMT~Mean~.

### Association between IMR and carotid atherosclerosis

The prevalence of carotid plaque in the whole study population was 30.8% ([Table I](#tI-etm-0-0-7646){ref-type="table"}) and increased progressively and significantly between risk 1 (1 risk factor) and risk 2 (2 risk factors) for CHD (chi-square test P\<0.05; [Table II](#tII-etm-0-0-7646){ref-type="table"}). The subjects were then stratified based on the presence of carotid plaque (absence=0, presence=1). IMR was significantly higher in subjects with carotid plaque than in subjects without carotid plaque (103.6±7.1 vs. 57.9±3.6 µm; P\<0.001; [Fig. 2D](#f2-etm-0-0-7646){ref-type="fig"}).

In a further analysis, all subjects were divided into three groups according to IMR tertiles. There was a significant increase in the prevalence of carotid plaque across the tertiles of IMR (4.9, 33.9 and 53.2% in tertiles 1, 2 and 3, respectively; P\<0.05; [Table IV](#tIV-etm-0-0-7646){ref-type="table"}). Compared with those subjects in the lowest tertile of IMR, those in the intermediate and highest tertiles had a significantly elevated OR regarding the presence of plaque in the carotid tree (intermediate tertile, OR=9.90, 95%CI: 2.77--35.41, P\<0.001; highest tertile, OR=22.00, 95%CI: 6.22--77.81, P\<0.001). Logistic regression adjusted for age, sex, smoking status, obesity, hypertension, diabetes mellitus and hyperlipidemia indicated that there were still significantly increased ORs for those subjects in the highest tertile compared with the lowest tertile (OR=10.61, 95%CI: 2.15--52.49, P=0.004; [Table IV](#tIV-etm-0-0-7646){ref-type="table"}).

### Coefficient of variation of repeated measurement

The measurements of IMR demonstrated an intra-observer variability with a coefficient variation of 6.8% and interobserver variability with a coefficient variation of 9.4%. The Bland-Altman plots suggested that differences between the two measurements in inter-observer were similar throughout the range of IMR, with the difference between the two measurements in intra-observer also similar ([Fig. 3](#f3-etm-0-0-7646){ref-type="fig"}).

Discussion
==========

Atherosclerosis is the primary cause of vascular disease ([@b1-etm-0-0-7646]). The ability of non-invasive methods to detect atherosclerosis is a matter of clinical interest. Carotid IMT is a surrogate indicator of atherosclerosis for predicting cardiovascular and cerebrovascular outcomes ([@b21-etm-0-0-7646]). US represents a simple, non-invasive technique for the measurement of IMT, which is widely used to study the presence and progression of atherosclerosis ([@b22-etm-0-0-7646]--[@b24-etm-0-0-7646]). The increase in the IMT~Max~ and IMT~Mean~ is, however, only a part of the information that reflects the atherosclerotic lesions in the artery ([@b4-etm-0-0-7646]--[@b6-etm-0-0-7646]). IMR, describing the amount of variation of a set of IMTs, is expected to be able to quantify the irregularities of the IM layer. Certain studies have pointed out that besides IMT, a rough intimal surface is also a typical feature of atherosclerosis ([@b13-etm-0-0-7646]). Due to the limitation of measurement technology, research on IMR is rare. In the present study, computer-assisted analysis software was used to automatically track the IM layer, obtain the IMT value of each pixel in the region of interest and calculate its standard deviation to reflect the IMR. In a previous study by our group and in the present study, the Bland-Altman test demonstrated that measurement of the IMR was reproducible and was able to stably reflect the morphologic changes of the carotid IM ([@b25-etm-0-0-7646]).

Various risk factors influence IMT ([@b26-etm-0-0-7646]). In the present study, the IMR was also increased in association with several CHD risk factors, including age, hyperlipidemia, hypertension and cigarette smoking, and was significantly associated with FRS, which is a risk score and an index of cumulative cardiovascular risk commonly used for assessing the probability of heart attack or death from heart disease within 10 years ([@b16-etm-0-0-7646]). The results of Cheng *et al* ([@b27-etm-0-0-7646]) are similar to those of the present study where the presence of only one risk factor was associated with a significant increase in IMR and IMT. Furthermore, the IMR and IMT increased with the number of cardiovascular risk factors. It is worth noting that when the two risk factors are combined, only IMR is increased compared to the low-risk group (1 risk factor), whilst IMT displays no significant change. This indicates that the IMR is more sensitive to the influence of risk factors than the IMT. The reason may be that IMR is more sensitive to atherosclerosis than IMT. Atherosclerosis is an inflammatory disease with the characteristics of inconsistent lesion degree of vascular segments ([@b15-etm-0-0-7646],[@b28-etm-0-0-7646]). Local inflammation occurs during the formation of plaque ([@b29-etm-0-0-7646]), which leads to roughness of the IM layer. Therefore, IMR reflects atherosclerotic changes in the vascular wall. Although the IMT is highly associated with atherosclerosis, increasing IMT may not always be due to atherosclerosis. Homma *et al* ([@b7-etm-0-0-7646]) indicated that increasing IMT at plaque-free sites does not indicate atherosclerotic changes and reflects diffuse physiologic aging processes as diffuse intimal thickening.

In the present study, IMR was significantly higher in subjects with carotid plaque than in subjects without carotid plaque. For cases with IMR \>84.8 µm, the prevalence of plaque in the carotid arteries is 11 times higher than in subjects with IMR \<33.8 µm (cut-off values selected from IMR tertiles), adjusted for age, sex, smoking status, obesity, hypertension, diabetes mellitus and hyperlipidemia. This result demonstrates that IMR may be used as a novel indicator to evaluate the risk of atherosclerosis, which is consistent with the results of other studies. Graf *et al* ([@b30-etm-0-0-7646]) revealed that the morphologic characteristics of the CCA (IMT inhomogeneity) are positively correlated with the degree of carotid bulb stenosis. Furthermore, as reported by Luijendijk *et al* ([@b4-etm-0-0-7646]) and Ishizu *et al* ([@b31-etm-0-0-7646]), the IMR of healthy subjects and patients with manifest coronary artery disease are significantly different. Belcaro *et al* ([@b11-etm-0-0-7646]) described these changes as granulations of the IM layer and developed a morphologic classification system of arterial wall changes. A 6-year follow-up was performed on 2,322 asymptomatic subjects, revealing that this structural alteration was a major criterion for future cardiovascular events. Therefore, it is necessary for subjects with IMR ≥84.8 µm to be followed up closely, even if these subjects may not have combined carotid plaque and risk factors.

IMR has a potential application scope in future clinical practice: i) IMR may indicate atherosclerotic lesions prior to IM thickening, which may be the earliest morphological non-invasive index of atherosclerotic lesions that is detectable at present. ii) IMR as an indicator of cardiovascular risk may help to develop a clinical treatment strategy. iii) Due to the examination being non-invasive, simple and easy to repeat, IMR is a suitable parameter to effectively monitor the therapeutic effect of statins in carotid atherosclerotic lesions. With more studies supporting the diagnostic value of IMR, its clinical application prospects will be broader.

The present study had several limitations. Due to technical constraints, IMR and IMT were measured only at the straight artery, while the curved vascular segments and the plaques were avoided. Thus, the region of interest selected may not have been that with the most severe atherosclerosis. Furthermore, IMR and IMT require measurement with post-processing software following storage of the US image. Furthermore, the quality of the US image may affect the measurement with this analysis software. As another limitation, intracranial arteries cannot be examined using IMR scans. In addition, prospective studies are required to demonstrate the predictive effect of IMR regarding the risk of cardiovascular events.

In conclusion, IMR measurement of the CCA quantified in US images based on this computer-assisted analysis software is feasible. Carotid IMR, which reflects the morphological changes of the IM layer, may help estimate the extent of atherosclerosis and may be used for risk stratification of patients with cardiovascular risk factors.
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![Carotid IMT and intima-media roughness measurements. (A) Ultrasound image of carotid longitudinal axis (depth 2.5 cm) (B) On ultrasound images, the carotid intima-media boundary is delineated by software. (C) Curve of IMT in the region of interest. IMT, intima-media thickness.](etm-18-01-0049-g00){#f1-etm-0-0-7646}

![Correlation between IMR, IMT and cardiovascular risk factors. (A) Correlation between IMR and Framingham risk score. (B) IMR according to tertiles of cardiovascular risk factor score. (C) IMR according to numbers of cardiovascular risk factors. (D) IMR according to carotid plaques. IMT, intima-media thickness; IMR, intima-media roughness.](etm-18-01-0049-g01){#f2-etm-0-0-7646}

![Intra-observer and inter-observer variability of IMR measurement. (A) Intra-observer variability of IMR measurement (n=30, r=0.974, CV=6.8%). (B) Inter-observer variability of IMR measurement (n=30, r=0.937, CV=9.4%). (C and D) Bland-Altman plots indicating that differences between the two measurements were similar throughout the range of IMR. IMR, intima-media roughness; CV, coefficient of variation.](etm-18-01-0049-g02){#f3-etm-0-0-7646}

###### 

Characteristics of all subjects.

  Parameter                     Total (n=185)   Range             Males (n=112)   Females (n=73)
  ----------------------------- --------------- ----------------- --------------- ----------------------------------------------------------
  Age (years)                   50.1±1.0        19--87              48.6±1.3        52.3±1.4
  Smoking                       52 (28.1)                         52 (46.4)       0 (0)^[a](#tfn1-etm-0-0-7646){ref-type="table-fn"}^
  Hypertension                  56 (30.3)                         30 (26.8)       26 (35.6)
  Diabetes                      77 (41.6)                         52 (46.4)       25 (34.2)
  Hyperlipidemia                53 (28.6)                         35 (31.3)       18 (24.7)
  Anthropometric measurements                                                     
    SBP (mmol/l)                130.3±1.8         92--240         129.1±2.0       132.3±3.4
    DBP (mmol/l)                  82.4±1.0        60--140           82.1±1.2        83.1±1.6
    BMI (kg/m2)                   23.8±0.2      16.7--32.3          24.3±0.3        22.9±0.4^[b](#tfn2-etm-0-0-7646){ref-type="table-fn"}^
  Blood lipids                                                                    
    FBG (mmol/l)                  7.0±0.3         2.1--33.4         6.9±0.3         7.1±0.5
    TG (mmol/l)                   1.8±0.1       0.4--9.0            1.7±0.1         1.8±0.2
    TC (mmol/l)                   4.7±0.1         0.6--21.5         4.6±0.2         4.8±0.2
    HDL-C (mmol/l)                1.4±0.1       0.5--9.4            1.4±0.1         1.5±0.1
    LDL-C (mmol/l)                2.4±0.1       0.4--7.2            2.4±0.1         2.5±0.1
  Ultrasonic measurements                                                         
    IMR (µm)                      72.0±3.6        10.9--230.0       74.5±4.8        68.1±5.7
    IMT~Mean~ (µm)                675.3±12.8      372.0--1354.2     685.1±16.4      660.4±20.5
    IMT~Max~ (µm)                 822.6±22.2      430.6--2217.9     843.7±28.5      790.2±35.5
    IMT~Min~ (µm)               565.0±9.9         294.0--1018.4     573.9±13.4      551.3±14.2
  Plaque                        57 (30.8)                         32 (28.6)       25 (34.2)

P\<0.01 (Chi-square test)

P\<0.01 (t-test). Values are expressed as the mean ± standard error of the mean or n (%). SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; FBG, fasting blood glucose; TG, triacylglycerol; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; IMR, intima-media roughness; IMT~Mean/Max/Min~, mean/maximum/minimum intima-media thickness.

###### 

Characteristics of subjects according to number of risk factors for coronary heart disease.

                       Number of risk factors                                                                                                                                                                         
  -------------------- ------------------------ ------------------------------------------------------------ -------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------
  Number of patients   40                       43                                                           53                                                                                                       49
  Age (years)            39.6±1.5                 51.0±2.2^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"}^       52.2±1.7^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"}^                                                   55.6±1.7^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"}^
  Males                17 (42.5)                30 (71.4)^[d](#tfn7-etm-0-0-7646){ref-type="table-fn"}^      31 (58.5)^[d](#tfn7-etm-0-0-7646){ref-type="table-fn"}^                                                  34 (69.4)^[d](#tfn7-etm-0-0-7646){ref-type="table-fn"}^
  SBP                  119.0±1.3                120.9±1.5                                                      134.2±4.1^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"},[b](#tfn5-etm-0-0-7646){ref-type="table-fn"}^     144.3±4.1^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"}--[c](#tfn6-etm-0-0-7646){ref-type="table-fn"}^
  DBP                    78.5±1.0                 78.6±0.9                                                     85.1±2.3^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"},[b](#tfn5-etm-0-0-7646){ref-type="table-fn"}^      86.5±2.2^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"},[b](#tfn5-etm-0-0-7646){ref-type="table-fn"}^
  BMI                    22.4±0.4                 24.1±0.4                                                   23.2±0.4                                                                                                 25.1±0.5
  FBG                    5.2±0.1                  5.8±0.4                                                      7.5±0.7^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"},[b](#tfn5-etm-0-0-7646){ref-type="table-fn"}^       9.0±0.5^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"}--[c](#tfn6-etm-0-0-7646){ref-type="table-fn"}^
  TG                     1.1±0.1                  1.4±0.2                                                      1.9±0.2^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"}^                                                    2.4±0.2^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"}--[c](#tfn6-etm-0-0-7646){ref-type="table-fn"}^
  TC                     4.5±0.1                  4.6±0.2                                                      4.5±0.2                                                                                                  5.0±0.4
  HDL                    1.7±0.1                  1.4±0.1                                                      1.3±0.1                                                                                                  1.4±0.2
  LDL                    2.4±0.1                  2.5±0.1                                                      2.4±0.1                                                                                                  2.6±0.2
  Smoking (%)          0 (0)                    12 (27.9)^[d](#tfn7-etm-0-0-7646){ref-type="table-fn"}^      18 (34.0)^[d](#tfn7-etm-0-0-7646){ref-type="table-fn"}^                                                  22 (44.9)^[d](#tfn7-etm-0-0-7646){ref-type="table-fn"}^
  IMR                    32.9±2.7                 64.5±6.9^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"}^       89.1±7.4^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"},[b](#tfn5-etm-0-0-7646){ref-type="table-fn"}^      92.0±6.7^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"},[b](#tfn5-etm-0-0-7646){ref-type="table-fn"}^
  IMT~Mean~              551.4±19.9               672.4±21.5^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"}^     708.8±24.9^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"}^                                                 742.9±25.3^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"},[b](#tfn5-etm-0-0-7646){ref-type="table-fn"}^
  IMT~Max~               637.3±30.4               810.9±40.0^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"}^     875.4±46.3^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"}^                                                 927.0±43.9^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"},[b](#tfn5-etm-0-0-7646){ref-type="table-fn"}^
  IMT~Min~               476.9±18.0               580.8±17.2^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"}^     594.3±18.9^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"}^                                                 591.2±19.6^[a](#tfn4-etm-0-0-7646){ref-type="table-fn"}^
  Plaque (%)           2 (5.0)                  7 (16.3)                                                     24 (45.3)^[d](#tfn7-etm-0-0-7646){ref-type="table-fn"},[e](#tfn8-etm-0-0-7646){ref-type="table-fn"}^     24 (49.0)^[d](#tfn7-etm-0-0-7646){ref-type="table-fn"},[e](#tfn8-etm-0-0-7646){ref-type="table-fn"}^

The following risk factors were considered: Age ≥55 years, diabetes, dyslipidemia, obesity, current smoking and hypertension.

P\<0.05 vs. 0 risk factors

P\<0.05 vs. 1 risk factor

P\<0.05 vs. 2 risk factors (analysis of variance with least-significant differences test).

P\<0.05 vs. 0 risk factors

P\<0.05 vs. 1 risk factor (Chi-square test). Values are expressed as the mean ± standard error of the mean or n (%). SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; FBG, fasting blood glucose; TG, triacylglycerol; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; IMR, intima-media roughness; IMT~Mean/Max/Min~, mean/maximum/minimum intima-media thickness.

###### 

Univariate and multivariate associations between IMR, IMT~Mean~ and cardiometabolic parameters.

                   IMR                                                    IMT~Mean~                                                                                                     
  ---------------- ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------
  Age              0.361^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^   0.292^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^   0.447^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^   0.376^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^
  SBP              0.353^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^   0.266^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^   0.328^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^   0.225^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^
  DBP              0.255^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^                                                          0.224^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^   
  Smoking          0.263^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^   0.289^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^   0.207^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^   0.191^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^
  FBG              0.131                                                                                                         0.102                                                  
  BMI              0.142                                                                                                         0.165^[a](#tfn9-etm-0-0-7646){ref-type="table-fn"}^    
  TC/HDL-C ratio   0.222^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^   0.193^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^   0.157^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^   0.142^[b](#tfn10-etm-0-0-7646){ref-type="table-fn"}^

P\<0.05

P\<0.01. SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; FBG, fasting blood glucose; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; IMR, intima-media roughness; IMT~Mean~, mean intima-media thickness.

###### 

ORs for the influence of IMR in different tertiles on carotid atherosclerosis in all subjects.

  IMR         n    Plaque                                                                                                     Crude OR (95%CI)       Crude P-value   Adjusted OR (95%CI)    Adjusted P-value
  ----------- ---- ---------------------------------------------------------------------------------------------------------- ---------------------- --------------- ---------------------- ------------------
  Tertile 1   61   3 (4.9)                                                                                                    1.00                   --              1.00                   --
  Tertile 2   62     21 (33.9)^[a](#tfn12-etm-0-0-7646){ref-type="table-fn"}^                                                   9.90 (2.77--35.41)   \<0.001           3.32 (0.72--15.37)   0.124
  Tertile 3   62     33 (53.2)^[a](#tfn12-etm-0-0-7646){ref-type="table-fn"},[b](#tfn13-etm-0-0-7646){ref-type="table-fn"}^   22.00 (6.22--77.81)    \<0.001         10.61 (2.15--52.49)    0.004

Logistic regression adjusted for age, sex, smoking, obesity, hypertension, diabetes mellitus and hyperlipidemia.

P\<0.01 vs. Tertile 1

P\<0.05 vs. Tertile 2 (Chi-square test). Tertile 1 is the reference group. OR, odds ratio; IMR, intima-media roughness.

[^1]: Contributed equally
